- Home
- AUTL vs HPI Comparison
AUTL vs HPI Comparison
Compare AUTL & HPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUTL | HPI |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.2M | 433.9M |
| IPO Year | 2025 | 2002 |
Fundamental Metrics
Financial Performance| Metric | AUTL | HPI |
|---|---|---|
| Price | $1.51 | $16.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 63.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $669.62 | N/A |
| Revenue Next Year | $79.78 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.11 | $14.61 |
| 52 Week High | $2.70 | $17.61 |
Technical Indicators
Market Signals| Indicator | AUTL | HPI |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 42.35 |
| Support Level | $1.27 | $15.71 |
| Resistance Level | $1.52 | $16.28 |
| Average True Range (ATR) | 0.11 | 0.14 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 16.35 | 21.28 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About HPI John Hancock Preferred Income Fund of Beneficial Interest
John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high-level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.